BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 660467)

  • 1. Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.
    Garceau Y; Davis I; Hasegawa J
    J Pharm Sci; 1978 Jun; 67(6):826-31. PubMed ID: 660467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluorometric determination of propranolol and its metabolite n-desisopropylpropranolol in plasma and urine by direct meausrement of thin-layer chromatographic plates (author's transl].
    Schäfer M; Geissler HE; Mutschler E
    J Chromatogr; 1977 Nov; 143(6):607-13. PubMed ID: 556337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine.
    Lo MW; Silber B; Riegelman S
    J Chromatogr Sci; 1982 Mar; 20(3):126-31. PubMed ID: 7076780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
    Schneck DW; Pritchard JF; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):3-12. PubMed ID: 432438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of alpha-naphthoxylactic acid, a major metabolite of propranolol, in plasma by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Dixon ST; McLean AJ
    J Chromatogr; 1986 Jan; 374(1):223-5. PubMed ID: 3949934
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct high-performance liquid chromatographic determination in urine of the enantiomers of propranolol and its major basic metabolite 4-hydroxypropranolol.
    Herring VL; Johnson JA
    J Chromatogr; 1993 Feb; 612(2):215-21. PubMed ID: 8468379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. IV. A rapid microscale method for determination of propranolol and 4-hydroxypropranolol in plasma.
    Sood SP; Green VI; Mason RP
    Ther Drug Monit; 1988; 10(2):224-30. PubMed ID: 3381242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in serum.
    Abdel-Hamid ME
    J Clin Pharm Ther; 1988 Jun; 13(3):183-9. PubMed ID: 3209625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
    Pritchard F; Schneck D; Hayes A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLC determination of griseofulvin in plasma and 6-demethylgriseofulvin in urine.
    Garceau Y; Brisson J; Davis I; DeAngelis RL; Hasegawa J
    J Pharm Sci; 1980 May; 69(5):561-3. PubMed ID: 7381744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
    Wong L; Nation RL; Chiou WL; Mehta PK
    Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of propranolol and 4-hydroxypropranolol in human plasma by high-performance liquid chromatography.
    Fu CW; Mason WD
    Analyst; 1989 Oct; 114(10):1219-23. PubMed ID: 2619067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of propranolol in the human maternal-placental-foetal unit.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and simultaneous extraction of propranolol, its neutral and basic metabolites from plasma and assay by high-performance liquid chromatography.
    Harrison PM; Tonkin AM; Cahill CM; McLean AJ
    J Chromatogr; 1985 Oct; 343(2):349-58. PubMed ID: 4066876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography.
    Walle T; Morrison J; Walle K; Conradi E
    J Chromatogr; 1975 Nov; 114(2):351-9. PubMed ID: 417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of propranolol intake by direct chromatographic detection of alpha-naphthoxylactic acid in urine.
    Ruiz-Angel MJ; Fernández-López P; Murillo-Pulgarín JA; García-Alvarez-Coque MC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):277-83. PubMed ID: 11885857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct determination of 1-naphthoxylactic acid in biological fluids by non-protected fluid room temperature phosphorimetry.
    Murillo Pulgarín JA; Alañón Molina A
    Fresenius J Anal Chem; 2000 Nov; 368(5):505-10. PubMed ID: 11227534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.
    Rosseel MT; Bogaert MG
    J Pharm Sci; 1981 Jun; 70(6):688-9. PubMed ID: 7252820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma.
    Smith MT; Livingstone I; Hooper WD; Eadie MJ; Triggs EJ
    Ther Drug Monit; 1983; 5(1):87-93. PubMed ID: 6845404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.